1. In vitro evaluation of anticancer drugs against ovarian cancer at concentrations achievable by intraperitoneal administration;Alberts;Semin Oncol,1985
2. Phase I clinical and pharmacokinetic study of mitoxantrone given to patients by intraperitoneal administration;Alberts;Cancer Res,1988
3. Conventional versus high dose intensity regimen of cisplatin in advanced ovarian carcinoma: A prospective randomized study;Bella;Proc Am Soc Clin Oncol,1992
4. Consolidation with intraperitoneal cisplatin in first-line therapy of advanced ovarian cancer;Beller;J Clin Oncol,1991
5. Intraperitoneal recombinant a-interferon for salvage immunotherapy in stage III epithelial ovarian cancer: A Gynecologic Oncology Group study;Berek;Cancer Res,1985